The global blood fluid warming system market size is expected to be valued at USD 1,083.8 million in 2023. With accidents, mishaps, and bullet wounds taking a toll on human lives, hypothermic fatalities nearing 1,300 during the last decade, plus an aging populace and childbirth driving incessant growth, industry growth for the blood fluid warming system market is witnessing an overall demand. The industry is projected to record a CAGR of 7.6% between 2023 to 2033, totaling around USD 2,264.6 million by 2033.
| Data Points | Key Statistics |
|---|---|
| Blood fluid warming system Market Value 2023 | USD 1,083.8 million |
| Blood fluid warming system Market Projected Value (2033) | USD 2,264.6 million |
| Blood fluid warming system Market CAGR (2023 to 2033) | 7.6% |
The blood fluid warming system comes into realization when the body temperature falls below 98.6 degrees Fahrenheit, nearing 95 degrees Fahrenheit. This medical condition is called hypothermia and is related to heat generated by the body and heat loss produced for a longer interval. Warm clothing is the recourse for hypothermia.
It has been seen that moderate environments also can lead to hypothermia with dependence on age, overall metabolism, body mass, and duration of exposure to cold climates. The device used in this process is called a blood warmer, which warms the blood to a safe level enough for infusion. Hypothermia could also be a result of medical complications such as diabetes, thyroid conditions, severe traumatic conditions, and drug abuse or alcohol intake.
Likewise, increasing the average life expectancy of individuals is another key factor stoking the blood fluid warming system market. Clinically, the occurrence of hypothermia is mostly observed in the elderly and infants; hence, increasing infant and geriatric populations are driving the blood fluid warming system market. The device finds specific use in emergency settings, ICUs, and operating rooms so as to prevent the prevalence of hypothermic conditions. The blood warmer comprises automatic adjustment of temperature to flow rate and a clearly audible alarm system.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Hypothermia also comes in an untimely moment when a person is being operated upon under anesthesia. He cannot regulate the blood flow and maintain body temperature, and hence the blood warming systems are required to avoid complications related to unheralded hypothermia. Blood fluid/warming systems have come into significance because of increasing hypothermia cases. Telling figures, indicative of 1,301 deaths due to hypothermia during the past decade, are factors driving the blood fluid warming systems.
The market is singled out over the forecast period due to an increase in surgeries and trauma cases worldwide. Trauma is a prime cause of death worldwide, with around 5 million people dying yearly due to traumatic injury. According to the Association for Safe International Road Travel (ASIRT) 2018, every year, between 19 and 45 million individuals are injured or disabled in traffic accidents, with 1.35 million related deaths.
According to WHO, road traffic injuries are estimated to be the ninth leading cause of mortality globally. In addition, hypothermia is one of the leading causes of death in patients who have suffered physical trauma.
For Instance:
Out of the few million occurrences of IV-induced hypothermia reported in the United States, 70.0% occur in ambulatory settings. Portable blood/IV warmers have been in prestigious demand in the United States and Europe since 2010, owing to the risk of freezing cold-stored blood/IV-induced hypothermia, expected to drive the industry throughout the forecast period.
Hypothermia also finds infants and the geriatric population easy prey. With the infant birthrate increasing the world over, fueling demand for blood fluid warming systems, hypothermic systems are increasing at a high rate. Technological improvements and the emergence of new players in the upcoming field are creating fierce competition in the market.
The growing demand for blood warmers from non-conservative end-users operating in extreme-freezing environments, including military activities, rescue services, and ambulatory care, is likely to drive market growth. The blood fluid warming system is commonly used in prehospital emergency settings, such as ambulances, rescue helicopters, and rapid response vehicles.
Principal Consultant
Low Awareness in Emerging Economies
Low awareness of blood-warming systems in emerging economies may limit the market growth in these regions.
Non-portable Blood Fluid Warmers Gain Recognition
The non-portable blood-IV fluid warmers segment held a leading market share of 55.5% in 2022. The growing onus of road accidents, mishaps, gunshot wounds, and other injuries is expected to drive segment growth. In addition, the increasing rate of hospitalization due to various medical disorders, the rising aging population, and improving financing for healthcare infrastructure in developing economies are all likely to propel market growth.
Surgical procedures and hospital admissions are the biggest factors that drive the need for infusion of IV solutions or blood transfusion. Blood warmers have traditionally been a vital link in minimizing mortality among citizens of industrialized countries due to transfusion/infusion-caused hypothermia, which drives segment growth.
However, the portable blood/IV warmers segment is projected to capture a CAGR of 8.45% from 2023 to 2033. The demand is expected to remain on the waxing side, greater than non-portable devices in the forthcoming years. A majority of the demand comes from ambulatory/paramedic services, rescue forces, and defense sectors.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Region | North America |
|---|---|
| Market Share % (2022) | 36.7% |
North America posted a staggering 36.7% market share value in the blood fluid warming system market in 2022. North America is a highly prevailing market in blood fluid warming systems, as proven by the increasing adoption of blood fluid warming systems coupled with increasing cases of hypothermia in this region.
North America, among them, dominates the blood fluid warming system market, followed by Europe. Subpar temperatures in most parts of the regions for several months in a year and the prevalence of ice skating wherein accidents and mishaps result in exposure to freezing temperatures puts ahead the demand for blood fluid warming systems. This bolsters the blood fluid warming system market in these regions.
The spiraling figures in hypothermia-related cases, along with the growing prevalence of chronic conditions such as thyroid and diabetes, is a vital factor leading to increased demand for blood warmers. For instance, according to CDC’s National Diabetes Statistics Report for 2020, in 2018, about 34.2 million people in the United States had diabetes. In addition, the rise in surgeries is expected to boost the market, as blood warmers play a decisive role in surgical care. For instance, as per the American Society for Aesthetic Plastic Surgery, surgical procedures accounted for 70% of the total expenditure in 2017 in the United States. Thus, these factors are expected to positively impact the market during the forecast period. Moreover, favorable reimbursement coverage is another key factor contributing to the growth of the industry in the United States.
| Country | Market CAGR % (2023 to 2033) |
|---|---|
| China | 8% |
| India | 7.8% |
Asia Pacific is witnessing comparatively high growth compared to other regions, mainly due to the growth in diabetics in the region. An aging population on the rise is expected to drive the Asia Pacific market. Eastern Europe and Japan are also expected to gain substantial growth due to cold temperatures in this region.
Middle East and Africa, and Latin America witnessed sloppy growth due to lower incidences of hypothermia in these regions. However, changing demographics and healthcare spending may boost the blood/fluid warming system in the Middle East and Africa, and Latin America.
Danish Firm Launches New Blood and IV Fluid Warming Device
In Apr 2021, Danish medtech company, MEQU, has launched an in-hospital solution for its blood and IV fluid warming device, M Warmer System. M Warmer System is a portable blood and IV fluid warming device utilized in the pre-hospital and military sectors. Using a patented warming technology, the M Warmer is able to warm infusion fluids from cold to body temperature in under 10 seconds.
Hotline Blood and Fluid Warmer
The hotline blood and fluid warmer offers a safe and reliable technology to consistently warm and deliver blood and fluids to patients undergoing surgical procedures.
In May 2022, Quantum Blood and Fluid Warming System from LifeWarmer was introduced. The product is a revolutionary innovation that has succeeded in closing a critical ability divide previously left exposed by other commercial off-the-shelf fluid warmers currently fielded. Size, weight, performance, and ease of use are no longer handicaps to the delivery of whole blood in far forward and near point of injury (POI) prehospital casualty management.
The blood fluid warming system market is highly competitive, with several players doing the honors. Product innovation and product improvisations are key industry players' focus areas. Prominent players in the industry include Emit Corporation, The 3M Company, Smiths Medical, The 37 Company, Foshan Keewell, GE Healthcare, Meridian Medical Systems, CareFusion, Barkey GmbH, and Becton, Dickinson, and Company. The key trend in the blood fluid warning system market is the increase in hypothermic patients making the cut in cold regions.
EMIT Corporation designs, develops, manufactures, and sells devices for the treatment and prevention of hypothermia. EMIT Corporation has been awarded a five-year USD 20 million maximum contract, w.e.f February 20, 2020, from the Defense Logistics Agency Troop Support, Philadelphia, PA, for the purchase of its HypothermX Intravenous Fluid and Blood Warming Devices and related accessories on their electronic agenda.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 7.6% from 2023 to 2033 |
| Market Value in 2023 | USD 1,083.8 million |
| Market Value in 2033 | USD 2,264.6 million |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Product, Distribution Channel, Application, Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia & Oceania; The Middle East and Africa |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Singapore, Australia, New Zealand, GCC Countries, South Africa, Israel |
| Key Companies Profiled | 3M Healthcare; Becton, Dickinson, and Company; Boston Scientific Corporation; Barkey GmbH & Co. KG; Smith & Nephew Group plc.; General Electric Company; Cincinnati Sub-Zero Products LLC; Sino Medical-Device Technology Co., Ltd.; Meridian Medical Systems LLC; Estill Medical Technologies, Inc. |
The market will expand at a 7.6% CAGR from 2023 to 2033.
The market in 2023 totals USD 1,083.8 million.
The China will register an 8% CAGR until 2033.
By 2033, the market will reach USD 2,264.6 million.
North America generated 36.7% revenue in 2022.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Surface 5.2. Intravenous 5.3. Patient Blood 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 6.1. Hospitals 6.2. Clinics 6.3. E-Commerce 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. Acute Care 7.2. Preoperative Care 7.3. New Born Care 7.4. Homecare 7.5. Other Applications 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. 3M Healthcare 18.2. Becton, Dickinson, and Company 18.3. Boston Scientific Corporation 18.4. Barkey GmbH & Co. KG 18.5. Smith & Nephew Group plc. 18.6. General Electric Company 18.7. Cincinnati Sub-Zero Products LLC 18.8. Sino Medical-Device Technology Co., Ltd. 18.9. Meridian Medical Systems LLC 18.10. Estill Medical Technologies, Inc. 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Blood Fluid Warming System Market
